![CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films](https://www.investinweed.com/wp-content/uploads/Cure-Pharmaceutical-627x376.png)
The new patent builds on one of CURE’s key technology differentiators – loading higher amounts of drug active on an oral thin film (OTF) using its proprietary drug delivery system, CUREfilm™.
Read More
The initial product launch will include a variety of THC and CBD products for the Canadian market.
Read More
Kali-Extracts confirmed the company is partnering with Puration, Inc. to produce CBD infused coffee.
Read More
The facility is cGMP compliant and registered with the State of Utah Medical Marijuana, Inc. aims to increase production and warehousing capabilities.
Read More
The company will release financial results for its second quarter 2019 ended June 30, 2019, after the stock market closes on Tuesday, August 6, 2019.
Read More
Get stock alerts, news & related alerts straight to your inbox!